The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of cardiovascular surgery within the last year. (Circulation. 2013;127:e529-e534.) 
Summary: The prevalence of diabetes mellitus is increasing at an unprecedented rate, affecting nearly 8% of the population. Previous studies have demonstrated a potential benefit for surgical over interventional revascularization in this group of patients, perhaps because of the diffuse nature of coronary atherosclerosis in this population. Similarly, multiple studies have shown the superiority of bilateral internal mammary artery (BIMA) grafting over single internal mammary artery (SIMA) grafting in select populations. However, concerns about sternal wound infection have discouraged the use of BIMA grafting in diabetics. Therefore, we studied the long-term results of BIMA versus single internal mammary artery grafting in a large population of diabetic patients in whom BIMA grafting was broadly applied. Because of the uncontrolled surgical selection process for single internal mammary artery versus BIMA grafting, we applied propensity score matching to create matched sets of single internal mammary artery and BIMA patients among 1107 consecutive coronary artery bypass graft patients. Although there was no difference in operative mortality, morbidity, or sternal wound infection between groups, there was a clear long-term survival benefit, even among matched patients, for BIMA over single internal mammary artery grafting. Given the increasingly prevalence of diabetes mellitus, the high incidence of extensive coronary artery disease in diabetics, and the proven benefit of coronary artery bypass graft surgery as a strategy for revascularization, these findings address an issue of high clinical impact. Because the findings are compelling and radically alter current clinical practice, this research is novel and warrants serious attention from both future researchers and clinical decision makers.
Conclusions: Compared with SIMA grafting, BIMA grafting in propensity score-matched patients provides diabetics with enhanced survival without any increase in perioperative morbidity or mortality. 1 
Multiple Arterial Grafts Improve Late Survival of Patients Undergoing Coronary Artery Bypass Graft Surgery: Analysis of 8622 Patients With Multivessel Disease
Summary: Coronary artery revascularization strategies are evolving: new-generation drug-eluting stents that reduce the need for reintervention, better quantification of types of coronary artery disease that will benefit from stents (SYNTAX score), increased use of stents for multivessel disease, ongoing evaluation of stents for left main disease, new strategies for minimally invasive coronary artery bypass grafting including the use of robots, and hybrid procedures. In comparisons of these strategies, the impact on survival is arguably the most important criterion. It has long been accepted that using the left internal mammary artery to bypass the left anterior descending coronary artery is the gold standard and may confer the survival advantage reported for coronary artery bypass grafting compared with percutaneous coronary intervention in some studies. The survival advantage of additional arterial conduits has been debated. This study, which involved a large cohort of patients with multivessel disease, has shown that in isolated coronary artery bypass grafting performed >15 years ago with the use of left internal mammary artery (LIMA) to the left anterior descending coronary artery, bypassing the non-left anterior descending coronary artery targets with at least 1 additional arterial graft was an independent predictor of survival during the succeeding 15 years. The results were confirmed with both a propensity-matched analysis that includes 1153 patients in each group and a multivariate analysis that is able to control for all differences between the groups because of the power of the large cohort in the series. The significant survival advantage of multiple arterial grafts must be considered in patients with multivessel disease as various revascularization strategies are considered.
Conclusions:
In patients undergoing isolated coronary artery bypass graft surgery with LIMA to left anterior descending artery, arterial grafting of the non-left anterior descending vessels conferred a survival advantage at 15 years compared with SV grafting. It is still unproven whether these results apply to higher-risk subgroups of patients. Summary: Despite significant improvement in both surgical and medical management of coronary artery bypass graft patients, many experience significant perioperative morbidity that adversely affects quality of life and length of hospitalization and increases resource use. Angiotensin-converting enzyme inhibitors (ACEIs) have been proven effective in the care of cardiovascular patients with hypertensive heart disease and congestive heart failure; however, effect of ACEI on survival in patients undergoing coronary artery bypass graft surgery is equivocal. Unfortunately, ACEI treatment is usually held up before coronary artery bypass graft, primarily because of historical reports linking it to hemodynamic instability during the perioperative period and a larger need for vasoactive drug use and fluid administration. To address these issues, we designed a prospective, international, multi-institutional study that allowed determination of the impact of the current practice pattern of ACEI use on morbidity and mortality after coronary artery bypass graft surgery. We showed that continuation of ACEI therapy early after surgery or adding ACEI de novo postoperatively can be associated with marked improvement in cardiovascular and renal outcomes. Conversely, a practice of withdrawing ACEI treatment postoperatively is associated with poor inhospital nonfatal outcomes. The associated improvement in outcomes with ACEI therapy was not surprising, given the well-known benefits of blocking the renin-angiotensin-aldosterone system; however, it is alarming to learn that clinicians chose to acutely discontinue ACEI therapy in nearly 50% of patients after cardiac surgery. The present work confirms that acute withdrawal of ACEI therapy may be particularly harmful in the context of cardiac surgery, and attention to restore ACEI therapy soon after operation should be encouraged.
Conclusions: Our study suggests that withdrawal of ACEI treatment after coronary artery bypass graft surgery is associated with nonfatal in-hospital ischemic events. Furthermore, continuation of ACEI or de novo ACEI therapy early after cardiac surgery is associated with improved in-hospital outcomes. Summary: The Department of Veterans Affairs Randomized On/Off Bypass (ROOBY) trial is the largest trial to date to compare angiographic outcomes in off-pump versus on-pump coronary artery bypass graft (CABG) surgery. One-year follow-up angiography was obtained in 685 off-pump and 685 on-pump patients. Angiograms were analyzed in a blinded manner by intention to treat. Grafts were classified as patent (open versus closed) and were assessed for quality with the FitzGibbon classification system. Every patient was also assessed for effective revascularization, which was defined as follows: All 3 major coronary territories with significant disease were revascularized by a FitzGibbon A-quality graft to the major diseased artery, the graft was placed in proper position relative to native disease, and there were no new postanastomotic lesions. Effective revascularization has not been reported previously in a study of post-CABG graft patency. This study is the first randomized study of off-pump versus on-pump CABG to indicate that both graft patency and effective revascularization are clearly worse with off-pump CABG. FitzGibbon graft patency was worse for arterial, left internal mammary artery pedicle, and vein graft conduits. In addition, every coronary territory was revascularized less effectively with off-pump CABG. At the 1-year follow-up angiography, ≈50% of off-pump CABG patients had at least 1 coronary territory that was at risk for ischemia. Those patients with less effective revascularization had significantly more adverse cardiac events by 1 year after CABG.
Conclusions: Off-pump CABG resulted in significantly lower FitzGibbon A patency for arterial and saphenous vein graft conduits and less effective revascularization than on-pump CABG. At 1 year, patients with less effective revascularization had higher adverse event rates. 4 
Early Results of Fenestrated Endovascular Repair of Juxtarenal Aortic Aneurysms in the United Kingdom
Summary: The technique of fenestrated endovascular repair (f-EVAR) of aortic aneurysm has been developed for use in juxtarenal and pararenal aneurysms that do not have an adequate aneurysm neck to allow a standard endovascular repair. Existing literature is a source of optimism, but it has been predominantly from expert operators who have been involved in the development of complex endograft design. It remained unknown if their results could be reproduced in the wider clinical practice. This is an important question, because the use of this technique is expanding rapidly and outside the pioneering centers. The British Society for Endovascular Therapy launched this study with the purpose of establishing nationwide results of f-EVAR without selection or reporting biases. Every center in the United Kingdom with an established f-EVAR service collaborated for this study with the aim of including every f-EVAR done during the study period. Data were collected through the GLOBALSTAR online registry. This analysis of early results confirm that, in the United Kingdom, national results of f-EVAR are comparable to those from single-center series. This finding justifies the continued use and evaluation of the f-EVAR by means of a prospective multicenter study.
Conclusions:
In this national sample, fenestrated endovascular repair has been performed with a high degree of technical and clinical success. Late survival and target vessel patency are satisfactory. These results support continued use and evaluation of this technique for juxtarenal aneurysms, but illustrate the need for a more robust evidence base. Summary: Conventional coronary artery bypass grafting performed with the use of cardiopulmonary bypass is a well-validated treatment for patients with ischemic heart disease. Off-pump coronary artery bypass grafting (OPCAB) has been suggested to reduce the number of perioperative complications, especially in elderly patients. In a multicenter, randomized trial, we assigned 900 patients >70 years of age to conventional coronary artery bypass grafting or OPCAB surgery. The primary end point was to test the noninferiority of a composite end point of death, stroke, and myocardial infarction within 30 days postoperatively. According to the intention-to-treat analysis, statistically nonsignificant trends toward fewer perioperative strokes (2.2% versus 4.0%; P=0.12) but more myocardial infarctions (8.2% versus 5.6%; P=0.12) were seen in the OPCAB patients. The proportion of patients experiencing the combined end point within 30 days was 10.2% for conventional coronary artery bypass grafting and 10.7% for OPCAB. Hence, the noninferiority of OPCAB with the prespecified margin could not be confirmed. The mean number of grafts performed was significantly lower in the OPCAB group (2.9 versus 3.1; P=0.005). At the 6-month follow-up, mortality was 4.2% in the OPCAB group versus 4.7% in the conventional coronary artery bypass grafting group (P=0.75). Both groups showed significant improvement in selfassessed health-related quality of life after 6 months compared with preoperatively. We conclude that both conventional coronary artery bypass grafting and OPCAB are safe procedures improving quality of life when performed in elderly patients. No major differences in short-or intermediate-term outcomes were found.
Conclusions: Both conventional coronary artery bypass grafting and OPCAB are safe procedures that improved the quality of life when performed in elderly patients. No major differences in intermediateterm outcomes were found. However, the noninferiority of OPCAB with the prespecified margin could not be confirmed. 
Risk Score for Predicting Long-Term Mortality After Coronary Artery Bypass Graft Surgery
Summary: Bedside friendly risk scores that predict in-hospital or 30-day mortality after coronary artery bypass graft (CABG) surgery are currently available. However, there is a need for a risk score that predicts long-term mortality after CABG surgery. In this study, we developed a Cox proportional hazards model that predicts mortality up to 7 years after CABG surgery using patient baseline risk factors. From this model, we created a simplified risk score that can accurately predict long-term mortality after CABG surgery. This risk score can be conveniently used to estimate long-term mortality after CABG surgery for a patient for whom CABG surgery is indicated; such information can also be useful while considering CABG surgery as an option to treat coronary artery disease.
Conclusions:
The simplified risk score accurately predicted the risk of mortality after coronary artery bypass graft surgery and can be used for informed consent and as an aid in determining treatment choice.
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Preoperative Serum Brain Natriuretic Peptide and Risk of Acute Kidney Injury After Cardiac Surgery Summary: Cardiovascular disease and heart failure are highly prevalent among those who undergo cardiac surgery, contributing to hemodynamic stress that may be poorly characterized by clinical history. Consequently, natriuretic peptide biomarkers that better characterize this underlying physiology have become well established in the diagnosis and management of patients with heart failure. In this study, 1139 adults who underwent cardiac surgery were evaluated from 6 centers to establish whether preoperative brain natriuretic peptide (BNP) levels predict postoperative acute kidney injury (AKI; defined by Acute Kidney Injury Network definitions; at least mild AKI was a >0.3-mg/dL [26 μmol/L] or 50% rise in creatinine, and severe AKI was either a doubling of creatinine or the requirement of acute renal replacement therapy). In this high-risk cohort, AKI was common (at least mild AKI, n=407 [36%]; severe AKI, n=58 [5.1%]). After adjustment for different preoperative characteristics, preoperative BNP was a strong and independent predictor of mild and severe AKI. Compared with the lowest BNP quintile, the highest quintile had significantly higher risk of at least mild AKI (risk ratio, 1.87) and severe AKI (risk ratio, 3.17). After adjustment for clinical predictors, the addition of BNP improved the area under the curve to predict at least mild AKI and severe AKI. Compared with clinical parameters alone, BNP also improved risk prediction of AKI cases into lower and higher risk. Preoperative BNP level is associated with postoperative AKI in high-risk patients undergoing cardiac surgery and may be a valuable component of future efforts to improve preoperative risk stratification among surgical candidates.
Conclusions: Preoperative BNP level is associated with postoperative AKI in high-risk patients undergoing cardiac surgery. If confirmed in other types of patients and surgeries, preoperative BNP may be a valuable component of future efforts to improve preoperative risk stratification and discrimination among surgical candidates. 
Relationship Between Vein Graft Failure and Subsequent Clinical Outcomes After Coronary Artery Bypass Surgery
Summary: In our study, we showed that the composite of death, myocardial infarction, or revascularization occurred more frequently among patients who had any vein graft failure compared with those who had none (adjusted hazard ratio, 1.58; 95% confidence interval, 1.21-2.06; P=0.008). This was due mainly to more frequent revascularization in patients with vein graft failure (VGF) with no differences in death (adjusted hazard ratio, 1.04; 95% confidence interval, 0.71-1.52; P=0.85) or death or myocardial infarction (adjusted hazard ratio, 1.08; 95% confidence interval, 0.77-1.53; P=0.65) between patients with and without vein graft failure. Our findings suggest that the increased risk of repeat revascularization was not only from incidental findings on protocol-mandated angiography but also from clinical symptoms and/or objective evidence of ischemia. Vein graft failure rates were higher in patients with poor graft and target artery quality. The absolute number of failed grafts did not correlate with long-term clinical outcomes; however, the proportion of grafts with vein graft failure did. Emphasis should be directed toward selection of a good-quality vein conduit and preventing vein graft injury during harvesting. Beyond surgery, optimal secondary prevention, including medications and lifestyle modification, may have significant influence on prolonging vein graft patency and/or reducing clinical event rates in patients undergoing coronary artery bypass graft surgery. The high vein graft failure rate and its relationship with worse clinical outcomes call for more research on how to improve both short-and long-term vein graft patency in patients undergoing coronary artery bypass graft surgery.
Conclusions: VGF is common after coronary artery bypass graft surgery and is associated with repeat revascularization but not with death and/or myocardial infarction. Further investigations are needed to evaluate therapies and strategies for decreasing VGF to improve outcomes in patients undergoing coronary artery bypass graft surgery. 9 
Aortic Event Rate in the Marfan Population: A Cohort Study
Summary: Marfan syndrome is a genetic disease usually related to a mutation in the gene coding for FBN1. It is transmitted as a dominant autosomal disease. The genetic nature of the disease allows early diagnosis with familial screening. Progressive aortic dilatation leading to aortic dissection and rupture is the main life-threatening complication associated with the syndrome. Medical management includes β-blocker therapy and prohibition of intensive sports. Regular follow-up visits are crucial to evaluate the aortic diameter with echocardiography and the need for prophylactic aortic surgery. In the present study, the management of 732 patients followed these rules, and the value of 50 mm was our threshold for preventive aortic surgery. Using this strategy, we showed that the risk of aortic event (dissection, rupture, or sudden death) was <0.05%/y in the population with an aortic diameter <50 mm in the absence of known risk factors such as pregnancy, familial history of aortic dissection at a low diameter, or rapid increase in diameter. This risk increases with the diameter of the aorta at the level of the sinuses of Valsalva; this increase was >4-fold in the patients whose aorta was 50 to 54 mm compared with 45 to 49 mm. The 50-mm threshold at the level of Valsalva appears to be a reasonable threshold for proposing preventive aortic surgery in patients with Marfan syndrome.
Conclusions: Risk of sudden death or aortic dissection remains low in patients with Marfan syndrome and aortic diameter between 45 and 49 mm. Aortic diameter of 50 mm appears to be a reasonable threshold for prophylactic surgery.
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Outcomes for Mitral Valve Surgery Among Medicare Fee-for-Service Beneficiaries, 1999 to 2008
Summary: Mitral valve surgery is associated with substantial morbidity and mortality in older adults. Single-center studies have reported a decline over time in mortality after mitral valve surgery. Among a national sample of Medicare fee-for-service (FFS) beneficiaries ≥65 years of age, 30-day and 1-year mortality after isolated mitral valve surgery declined significantly from 1999 to 2008. Risk-adjusted 30-day readmission also declined, although to a smaller degree. Mortality rates remained higher in women and blacks across all years; in 2008, women and blacks were 16% and 15% more likely to die 1 year after mitral valve surgery, compared with men and whites, respectively. Rates of mitral valve repair increased from one-quarter to nearly onehalf of all mitral valve surgeries over the study period. Among states and territories, 29 of 52 experienced a significant decline in mortality, whereas mortality rates in the remainder were unchanged. 
Hospital Variation in Readmission After Coronary Artery Bypass Surgery in California
Summary: Readmissions are common after coronary artery bypass grafting surgery and account for a large proportion of hospital healthcare costs in this patient population. Readmission rates vary widely among hospitals, but the reasons for this variability are unknown. The top 2 reasons for readmission after coronary artery bypass grafting in this cohort in California were heart failure and infection. Patient demographic and clinical risk factors, rather than the hospital characteristics that were measured for this study accounted for most of the observed hospital-level variation in coronary artery bypass grafting readmissions.
Conclusions: California hospitals performing CABG surgery vary widely in 30-day readmission rates. Patient demographic and clinical risk factors, rather than measured hospital characteristics, accounted for most of the observed hospital-level variation in CABG readmissions.
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Long-Term Outcome of Stents Versus Bypass Surgery in Diabetic and Nondiabetic Patients With Multivessel or Left Main Coronary Artery Disease: A Pooled Analysis of 5775 Individual Patient Data
Summary: Coronary artery bypass graft and percutaneous coronary intervention (PCI) are alternative revascularization procedures for patients with multivessel or left main coronary artery disease. The relative benefits of coronary artery bypass graft and percutaneous coronary intervention on patient outcomes (mortality, myocardial infarction, stroke, and repeat procedures) vary according to the presence or absence of diabetes mellitus, but previous studies provide conflicting data on long-term outcome. In this study, risk-adjusted long-term rates of mortality and serious composite outcomes are not different after percutaneous coronary intervention and coronary artery bypass graft both in diabetic and in nondiabetic patients with multivessel or left main coronary artery disease. However, the rate of repeat revascularization was higher in the percutaneous coronary intervention group. Due to the nonrandomized nature of data, these results are hypothesis generating and should be confirmed through large, randomized clinical trials.
Conclusions:
For multivessel or left main disease, the long-term risks of mortality and composite serious outcomes were not different between PCI and coronary artery bypass grafting in diabetic and nondiabetic patients, but PCI was associated with higher risk of repeat revascularization. These relative treatment effects were not modified by diabetic status. These results are hypothesis generating and should be addressed in a randomized trial.
13
Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?: Implications for Future Treatment Comparisons
Summary: The SYNTAX trial found that patients with left main or multivessel coronary disease treated with initial CABG surgery had lower rates of repeat revascularization and less angina than those treated with initial PCI. Using the SYNTAX population, we evaluated the relationship between initial treatment, repeat revascularization during follow-up, and angina at 1 year. We found that patients who underwent repeat revascularization had worse angina frequency scores than patients who did not in both treatment groups, similar to other studies. Among patients who did not undergo repeat revascularization, patients treated with CABG still had better angina relief at 12 months than patients treated with PCI, with an adjusted between-group difference similar to the treatment effect in the overall population. These findings suggest that some of the antianginal benefits of CABG may result from mechanisms unrelated to relief of myocardial ischemia (eg, denervation, placebo effects). The strength of association between repeat revascularization and angina was greater among patients treated with CABG as compared with those treated with PCI, indicating that the end point of repeat revascularization has a different clinical impact based on the original treatment and thus should play a limited role as an indirect measure of health outcomes between these 2 revascularization strategies.
Conclusions: Among patients with multivessel coronary artery disease treated with PCI or CABG, the occurrence of repeat revascularization during follow-up did not fully explain the antianginal benefit of CABG in the overall population. The differential association between repeat revascularization and anginal status, according to the type of initial revascularization procedure, suggests that this end point should play a limited role in any direct comparison of the 2 treatment strategies.
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Inhaled NO and Sildenafil Combination in Cardiac Surgery Patients With Out-of-Proportion Pulmonary Hypertension: Acute Effects on Postoperative Gas Exchange and Hemodynamics
Summary: In patients with left ventricular dysfunction undergoing cardiac surgery, the presence of pulmonary hypertension (PH) may adversely affect the outcome. Although left heart disease is the most common cause of PH, very few data on the pathophysiology and treatment of out-of-proportion PH due to left heart disease are available. Several previous studies have focused on either inhaled nitric oxide (iNO) or oral sildenafil administration in patients with PH. The combined use of these agents in patients with out-of-proportion PH due to left heart disease is not well documented. To our knowledge, this study is the first that evaluates the effects of oral sildenafil and iNO on hemodynamic and gas exchange when administered immediately postoperatively either alone or in combination in postoperative patients with out-of-proportion PH due to left valvular heart disease who underwent valve replacement surgery. The combination of sildenafil and iNO has an additive effect in decreasing pulmonary vascular pressure and resistance more than either alone. Further evidence of the salutary effect of this combination is that, in contrast to iNO alone, sildenafil unloaded the left ventricle, reducing both preload and afterload, whereas the iNO added to the sildenafil improved ventilation/perfusion mismatch (eliminated the decreased PaO 2 /FiO 2 ratio) induced by sildenafil alone. The findings of our study may suggest improved outcome of these patients and thus a new therapeutic approach, an insight that has to be confirmed by larger studies.
Conclusions:
In this study, the postoperative coadministration of iNO and oral sildenafil in patients with out-of-proportion pulmonary hypertension undergoing cardiac surgery is safe and results in an additive favorable effect on pulmonary arterial pressure and pulmonary vascular resistance, without systemic hypotension and ventilation/perfusion mismatch. Conclusions: Venous thromboembolism occurs infrequently after CABG. Compared with the use of no prevention, the administration of chemical or mechanical preventative therapies to CABG patients does not appreciably lower the risk of VTE. These data provide support for the common practice of administering no VTE preventative therapy after CABG, used for nearly 60% of patients within this cohort.
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Addition of Frailty and Disability to Cardiac Surgery Risk Scores Identifies Elderly Patients at High Risk of Mortality or Major Morbidity
Summary: Prediction of operative risk using available risk scores is less accurate in elderly patients referred for cardiac surgery. Elderly patients often present with a heavy burden of comorbidity, disability, and perceived frailty. Multiple scales exist to measure surgical risk as well as frailty and disability, yet the optimal combination of scales remains unknown. Frailty and disability provide incremental prognostic value above surgical risk scores for predicting mortality or major morbidity. The optimal combination of scales consists of the Parsonnet surgical risk score, 5-meter gait speed as a measure of frailty, and the Nagi scale as a measure of disability.
Conclusions: Clinicians should use an integrative approach combining frailty, disability, and risk scores to better characterize elderly patients referred for cardiac surgery and identify those that are at increased risk.
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Coronary Artery Bypass Graft: Contemporary Heart Surgery Center Performance in China Summary: In the United States, variation in patient outcomes after CABG has been documented. The current study can reveal whether Chinese hospitals are achieving good and uniform results, and if not, may provide insights in how to improve care. Our findings can inform practitioners and policymakers about what is being achieved and what can be done better. The mortality and complication rates from the 43 centers can be used as benchmarks to evaluate other Chinese CABG centers' performance. The ability and willingness to measure performance is an important milestone toward integrating improvement into the Chinese health care system.
Conclusions: Mortality and complication rates after CABG surgery in the Chinese Cardiac Surgery Registry are generally low but vary by hospital and region within China. These results suggest that there are opportunities to improve outcomes in some CABG facilities.
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Clinical Evidence, Practice Guidelines, and β-Blocker Utilization Before Major Noncardiac Surgery Summary: Largely on the basis of 2 randomized trials published in the 1990s, β-blockers were initially promoted for preventing cardiac complications of noncardiac surgery. Subsequent research cast doubts on both the efficacy and safety of perioperative β-blockade. 
